In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about
For those of us old enough to remember ringing in the year 2000, current concerns that artificial intelligence (AI) may usher in the end of the world as we know it may call to mind the fear
It’s honestly getting harder to separate AI-powered pharma companies from pharma-focused AI companies as AI becomes more and more embedded in biopharma operations.
Generative AI – large language models, or LLMs, like ChatGPT – has the potential to revolutionise almost any knowledge industry, and pharma is no exception.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.